Atlas Trials

Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults

Clinical trial NCT05252845 · COMPLETED

Trial details

NCT number
NCT05252845
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malaria,Falciparum
Start date
2023-01-04
Primary completion
2023-06-08
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.